M. Helmerking

发表

Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study

W. Hiddemann, G. Maschmeyer, H. Link, 1994, Cancer.

Diffusion of cefradine and cefalothin into interstitial fluid of human volunteers with tissue cages

B. Reichart, B. Kemkes, C. Weinhold, 2005, Infection.

Therapy of Sepsis Syndrome with Human Polyclonal IgM-Enriched Immunoglobulins: Interim Analysis of a Randomized Trial in Neutropenic Cancer Patients

W. Hiddemann, G. Behre, B. Wörmann, 1997 .

Antibiotic Treatment for Streptococcal Pharyngitis

D. Adam, M. Helmerking, 2004 .

Interventional antimicrobial therapy in febrile neutropenic patients. Study Group of the Paul Ehrlich Society for Chemotherapy.

W. Hiddemann, G. Maschmeyer, H. Link, 1994, Annals of hematology.

A Prospective, Randomized Multicenter Trial of the Empirical Addition of Antifungal Therapy for Febrile Neutropenic Cancer Patients: Results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial II

W. Hiddemann, X. Schiel, D. Buchheidt, 2006, Infection.

Interventional antimicrobial therapy in febrile neutropenic patients

W. Hiddemann, G. Maschmeyer, H. Link, 1994, Annals of Hematology.

Interventional Antimicrobial Strategy for the Management of Infections in Neutropenic Patients with Hematologic Malignancies: Results of a Multi-Center Randomized Comparison of Antimicrobial Regiments

W. Hiddemann, G. Maschmeyer, H. Link, 1994 .

[Empirical antimicrobial therapy in neutropenic patients. Results of a multicenter study by the Infections in Hematology Study Group of the Paul Ehrlich Society].

W. Hiddemann, G. Maschmeyer, H. Link, 1994, Medizinische Klinik.

Interventional Antimicrobial Strategy in Febrile Neutropenic Patients

W. Hiddemann, G. Maschmeyer, H. Link, 1990 .

Short-course antibiotic treatment of 4782 culture-proven cases of group A streptococcal tonsillopharyngitis and incidence of poststreptococcal sequelae.

H. Scholz, D. Adam, M. Helmerking, 2000, The Journal of infectious diseases.

Interventional Antimicrobial Therapy in Febrile Neutropenic Patients (PEG Study II)

T. Lipp, W. Hiddemann, V. Heinemann, 1998 .

Empirical Antimicrobial Therapy of FUO and Proved Infections in Neutropenic Patients

W. Hiddemann, D. Buchheidt, G. Maschmeyer, 2001 .

Interventional Antimicrobial Strategy in Neutropenic Infections

W. Hiddemann, G. Maschmeyer, H. Link, 1997 .

European Surveillance of Infections in Cancer Patients – ESIC

W. Hiddemann, X. Schiel, D. Buchheidt, 1999, Chemotherapy.

European Surveillance of Infections and Risk Factors in Cancer Patients

W. Hiddemann, J. Donnelly, X. Schiel, 1999, European Journal of Clinical Microbiology and Infectious Diseases.

[Treatment of group A streptococcal tonsillopharyngitis. 5 days cephalosporin is as effective as 10 days penicillin].

H. Scholz, D. Adam, M. Helmerking, 2001, MMW Fortschritte der Medizin.

Comparison of short-course (5 day) cefuroxime axetil with a standard 10 day oral penicillin V regimen in the treatment of tonsillopharyngitis.

H. Scholz, D. Adam, M. Helmerking, 2000, The Journal of antimicrobial chemotherapy.

Interventional antimicrobial strategy in febrile neutropenic patients. Results of a multicenter study in 1,260 patients with hematological malignancies. The Interventional Antimicrobial Strategy Study Group, Paul Ehrlich Society for Chemotherapy.

W. Hiddemann, G. Maschmeyer, H. Link, 1990, Onkologie.